Serum neurofilament light chain as a biomarker of disease activity in antibody-mediated autoimmune encephalitis

Key Points

• The research aims to evaluate serum neurofilament light chain as a potential biomarker for disease activity in autoimmune encephalitis.
• Assess serum neurofilament light levels in patients with autoimmune encephalitis.
• Analyze the correlation between serum neurofilament light levels and disease activity.
• Focus on patients with cell surface antibody-mediated autoimmune encephalitides.
• Serum neurofilament light levels correlate with disease activity in autoimmune encephalitis.
• Higher levels of serum neurofilament light are associated with increased disease severity.